Attached files
| file | filename |
|---|---|
| 10-K - 10-K - NPS PHARMACEUTICALS INC | form10k.htm |
| EX-21.1 - SUBSIDIARIES - NPS PHARMACEUTICALS INC | exh21-1.htm |
| EX-31.1 - CEO CERTIFICATE - NPS PHARMACEUTICALS INC | exh31-1.htm |
| EX-23.1 - CONSENT - NPS PHARMACEUTICALS INC | exh23-1.htm |
| EX-32 - 906 CERTIFICATE - NPS PHARMACEUTICALS INC | exh32.htm |
| EXCEL - IDEA: XBRL DOCUMENT - NPS PHARMACEUTICALS INC | Financial_Report.xls |
| EX-31.2 - CFO CERTIFICATE - NPS PHARMACEUTICALS INC | exh31-2.htm |
Exhibit 12.1
| Statement Regarding Computation of Ratio of Earnings to Fixed Charges | |||||||||||||||
| (in thousands) | |||||||||||||||
| Year Ended December 31, | |||||||||||||||
| 2010 | 2011 | 2012 | 2013 | 2014 | |||||||||||
| Earnings (loss) | |||||||||||||||
| Pre-tax loss | $ | (30,350) | $ | (36,249) | $ | (18,735) | $ | (13,322) | $ | (7,939) | |||||
| Total fixed charges | $ | 45,365 | $ | 38,157 | $ | 18,721 | $ | 12,504 | $ | 14,592 | |||||
| Total income before fixed charges | $ | 15,015 | $ | 1,908 | $ | (14) | $ | (818) | $ | 6,653 | |||||
| Fixed Charges | |||||||||||||||
| Interest expenses | $ | 45,128 | $ | 37,736 | $ | 18,198 | $ | 11,938 | $ | 13,728 | |||||
| Assumed interest attributable to rentals | $ | 237 | $ | 421 | $ | 523 | $ | 566 | $ | 864 | |||||
| Total fixed charges | $ | 45,365 | $ | 38,157 | $ | 18,721 | $ | 12,504 | $ | 14,592 | |||||
| Deficiency of earnings available to cover fixed charges | $ | 30,350 | $ | 36,249 | $ | 18,735 | $ | 13,322 | $ | 7,939 | |||||
| Ratio of earnings available to cover fixed charges | n/a | n/a | n/a | n/a | n/a | ||||||||||